UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 622

Sortiert nach

Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs

Antimicrobial agents and chemotherapy, 2016-08, Vol.60 (8), p.4840-4852

2016

Link zum Volltext

Verfügbarkeit prüfen

Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria

Antimicrobial agents and chemotherapy, 2017-06, Vol.61 (6)

2017

Link zum Volltext

Verfügbarkeit prüfen

Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Link zum Volltext

Verfügbarkeit prüfen

Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection

Antimicrobial agents and chemotherapy, 2016-01, Vol.60 (1), p.368-375

2016

Link zum Volltext

Verfügbarkeit prüfen

Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5527-5535

2013

Link zum Volltext

Verfügbarkeit prüfen

Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing

Antimicrobial agents and chemotherapy, 2016-12, Vol.60 (12), p.7415-7423

2016

Link zum Volltext

Verfügbarkeit prüfen

Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the In Vitro Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa

Antimicrobial agents and chemotherapy, 2019-04, Vol.63 (4)

2019

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and Bacterial Virulence

Antimicrobial agents and chemotherapy, 2020-01, Vol.64 (2)

2020

Link zum Volltext

Verfügbarkeit prüfen

Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections

Antimicrobial agents and chemotherapy, 2019-01, Vol.63 (1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Identification of FDA-Approved Drugs as Antivirulence Agents Targeting the pqs Quorum-Sensing System of Pseudomonas aeruginosa

Antimicrobial agents and chemotherapy, 2018-11, Vol.62 (11)

2018

Link zum Volltext

Verfügbarkeit prüfen

Ajoene, a Sulfur-Rich Molecule from Garlic, Inhibits Genes Controlled by Quorum Sensing

Antimicrobial Agents and Chemotherapy, 2012-05, Vol.56 (5), p.2314-2325

2012

Link zum Volltext

Verfügbarkeit prüfen

A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness

Antimicrobial agents and chemotherapy, 2017-09, Vol.61 (9)

2017

Link zum Volltext

Verfügbarkeit prüfen

Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants

Antimicrobial agents and chemotherapy, 2020-01, Vol.64 (2)

2020

Link zum Volltext

Verfügbarkeit prüfen

Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa Bacteremia

Antimicrobial Agents and Chemotherapy, 2012-09, Vol.56 (9), p.4833-4837

2012

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia

Antimicrobial agents and chemotherapy, 2019-04, Vol.63 (4)

2019

Link zum Volltext

Verfügbarkeit prüfen

Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung

Antimicrobial agents and chemotherapy, 2016-02, Vol.60 (2), p.744-751

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics

Antimicrobial agents and chemotherapy, 2017-09, Vol.61 (9)

2017

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015

Antimicrobial agents and chemotherapy, 2017-04, Vol.61 (4)

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Link zum Volltext

Verfügbarkeit prüfen

Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2008-10, Vol.52 (10), p.3648-3663

2008

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe

Antimicrobial agents and chemotherapy, 2016-11, Vol.60 (11), p.6735-6741

2016

Link zum Volltext

Verfügbarkeit prüfen

Extended-Infusion Cefepime Reduces Mortality in Patients with Pseudomonas aeruginosa Infections

Antimicrobial Agents and Chemotherapy, 2013-07, Vol.57 (7), p.2907-2912

2013

Link zum Volltext

Verfügbarkeit prüfen

Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor

Antimicrobial agents and chemotherapy, 2016-03, Vol.60 (3), p.1676-1686

2016

Link zum Volltext

Verfügbarkeit prüfen

Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure

Antimicrobial agents and chemotherapy, 2017-01, Vol.61 (1)

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 622

Suche als RSS-Feed

Aktive Filter

Publikationsformmagazinearticle

Zeitschrift / SerieAntimicrobial Agents And Chemotherapy

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(599)
Mit Volltextzugriff
(588)

Sprache

Englisch
(622)
Japanisch
(74)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(543)
Microbiology
(543)
Pharmacology & Pharmacy
(543)
Science & Technology
(543)
Pseudomonas Aeruginosa
(466)
Pseudomonas Infections - Drug Therapy
(451)
Humans
(439)
Pseudomonas Aeruginosa - Drug Effects
(343)
Biological And Medical Sciences
(322)
Medical Sciences
(320)
Pharmacology. Drug Treatments
(319)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(316)
Microbial Sensitivity Tests
(306)
Anti-Bacterial Agents
(287)
Pseudomonas Infections - Microbiology
(268)
Anti-Bacterial Agents - Pharmacology
(250)
Pseudomonas Infections
(249)
Female
(243)
Animals
(230)
Anti-Bacterial Agents - Therapeutic Use
(217)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(622)
Free E-Journal (出版社公開部分のみ）
(599)

Zeitschrift / Serie

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs

Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria

Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States

Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections

Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection

Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones

Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing

Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the In Vitro Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa

Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and Bacterial Virulence

Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections

Identification of FDA-Approved Drugs as Antivirulence Agents Targeting the pqs Quorum-Sensing System of Pseudomonas aeruginosa

Ajoene, a Sulfur-Rich Molecule from Garlic, Inhibits Genes Controlled by Quorum Sensing

A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness

Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants

Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa Bacteremia

Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia

Antipseudomonal Bacteriophage Reduces Infective Burden and Inflammatory Response in Murine Lung

Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics

Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015

Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model

Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosa

Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe

Extended-Infusion Cefepime Reduces Mortality in Patients with Pseudomonas aeruginosa Infections

Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor

Carbapenem-Resistant Pseudomonas aeruginosa Bacteremia: Risk Factors for Mortality and Microbiologic Treatment Failure

Aktive Filter

Suchergebnisse filtern